Open-label multi-center safety trial of fentanyl sublingual spray (fentanyl SL spray) for the treatment of breakthrough cancer pain.

Trial Profile

Open-label multi-center safety trial of fentanyl sublingual spray (fentanyl SL spray) for the treatment of breakthrough cancer pain.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 May 2014

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Cancer pain
  • Focus Adverse reactions
  • Sponsors INSYS Therapeutics, Inc
  • Most Recent Events

    • 23 Mar 2012 Additional lead trial investigator (Larry Dillaha) identified as reported by ClinicalTrials.gov.
    • 23 Mar 2012 Additional lead trial investigator (Larry Dillaha) identified as reported by ClinicalTrials.gov.
    • 03 Jun 2011 Actual end date changed from Nov 2007 to Dec 2007 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top